SOUTH
SAN FRANCISCO, Calif., Jan. 3, 2024
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today
announced that Raul Rodriguez, the
company's president and CEO, will present a company overview at the
42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 p.m. PT in San
Francisco, CA.
To access the live webcast or archived recording, visit the
Investor Relations section of the company's website at
www.rigel.com. Please connect to Rigel's website prior to the start
of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc.
(Nasdaq: RIGL) is a biotechnology company
dedicated to discovering, developing and providing novel therapies
that significantly improve the lives of patients with hematologic
disorders and cancer. Founded in 1996, Rigel is based
in South San Francisco,
California. For more information on Rigel, the
Company's marketed products and pipeline of potential products,
visit www.rigel.com.
Investors & Media Contacts:
Investors:
Rigel Pharmaceuticals,
Inc.
650.624.1232
ir@rigel.com
Media:
David
Rosen
Argot Partners
Phone:
212.600.1902
Email: david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025129.html
SOURCE Rigel Pharmaceuticals, Inc.